Prerequisites to Use Preservative-Free Drugs in Medication Therapy of Glaucoma

Prerequisites to Use Preservative-Free Drugs in Medication Therapy of Glaucoma

Purpose — to analyze the literature data on the benefits of preservative-free medication therapy for glaucoma.Materials and methods. 482 articles in the Pubmed database published from 1975 to 2020 were analyzed using the terms: “glaucoma”, “preservatives”, “preservative-free therapy”, “benzalkonium...

Full description

Bibliographic Details
Main Authors:	D. A. Dorofeev, A. Yu. Brezhnev, I. R. Gazizova, M. A. Glasunova, E. V. Kirilik, A. V. Kuroedov, A. V. Seleznev, A. G. Shukurov
Format:	Article
Language:	Russian
Published:	Ophthalmology Publishing Group 2021-10-01
Series:	Oftalʹmologiâ
Subjects:	glaucoma dry eye syndrome ocular surface pathology preservative-free therapy preservatives for eye drops benzalkonium chloride
Online Access:	https://www.ophthalmojournal.com/opht/article/view/1610

Similar Items

Managing Ocular Surface Disease in Glaucoma Treatment: A Systematic Review
by: Özlem Evren Kemer, et al.
Published: (2024-10-01)

Possibilities of Preservative-Free Therapy for Primary Open-Angle Glaucoma
by: S. V. Yanchenko, et al.
Published: (2023-12-01)

OCULAR SURFACE’S DISORDERS IN GLAUCOMA PATIENTS TREATED WITH LONG INSTILLATION OF BETA BLOCKERS WITH PRESERVATIVES
by: E. V. Varlashina, et al.
Published: (2017-07-01)

A phase III, multicentre, randomised, investigator-masked, cross-over, comparative, non-inferiority trial evaluating the efficacy and tolerability of generic preservative-free Latanoprost (Polpharma S.A.) compared to Xalatan® (Pfizer) in patients with ocular hypertension or primary open-angle glaucoma
by: Norbert Czumbel, et al.
Published: (2024-07-01)

Effect of sodium hyaluronate on the pathochemical process in the anterior eye segment when using benzalkonium chloride eye drops in glaucoma patients
by: V.I. Senishin
Published: (2016-08-01)

The Daily, Monthly, and Annual Cost of Glaucoma Therapy Using Ocular Hypotensive Eye Drops in the Philippines Based on a Quantitative Method
by: Corrina P. Azarcon, MD, et al.
Published: (2020-12-01)

Therapeutic Aqueous Humor Concentrations of Latanoprost Attained in Rats by Administration in a Very-High-Molecular-Weight Hyaluronic Acid Eye Drop
by: Kazunari Higa, et al.
Published: (2024-04-01)

Ocular Phantom-Based Feasibility Study of an Early Diagnosis Device for Glaucoma
by: Marie-Valérie Moreno, et al.
Published: (2021-01-01)

Possibilities of Preservative-Free Therapy for Primary Open-Angle Glaucoma
by: A. A. Antonov, et al.
Published: (2023-12-01)

New Opportunities in Non-Preservative Glaucoma Therapy
by: A. A. Antonov, et al.
Published: (2021-07-01)

Nanomedicine in glaucoma treatment; Current challenges and future perspectives
by: Haroon Iqbal, et al.
Published: (2024-10-01)

Prevalence of dry eye in patients using topical antiglaucoma medications
by: Erkut Küçük, et al.
Published: (2024-04-01)

Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the Hospital Pharmacy Departments
by: Anxo Fernández-Ferreiro, et al.
Published: (2016-12-01)

Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial
by: Eric Donnenfeld, et al.
Published: (2024-10-01)

When is preservative-free therapy of glaucoma needed and advisable?
by: T. N. Malishevskaya, et al.
Published: (2021-09-01)

Management of Glaucoma-Related Dry Eye Disease with Intense Pulsed Light: A Randomized Control Study
by: Zhang H, et al.
Published: (2024-07-01)

ROLE OF FIBEROPTIC BRONCHOSCOPY IN NON-RESOLVING PNEUMONIA
by: Punit Singh, et al.
Published: (2016-12-01)

Utilizing visual symptoms to distinguish dry eye from glaucoma, cataract, and suspect glaucoma patients: a cross-sectional study
by: David X. Zhao, et al.
Published: (2024-01-01)

Dry Eye Epidemiology in Patients before Cataract Surgery
by: S. N. Sakhnov, et al.
Published: (2020-06-01)

Ocular Surface Disease Signs and Symptoms in Patients with Pseudoexfoliative Glaucoma: A Case—Control Study
by: Maria Dermenoudi, et al.
Published: (2022-02-01)

New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma
by: A. S. Dukhanin, et al.
Published: (2024-06-01)

Experience in the Treatment of Dry Eye Syndrome in Students with Myopic Refraction
by: T. V. Gavrilova, et al.
Published: (2023-10-01)

Dry eye disease and associated factors in Kazakhstan and Uzbekistan
by: Q. B. Maskati, et al.
Published: (2021-06-01)

Dexamethasone acetate loaded poly(ε-caprolactone) nanofibers for rat corneal chemical burn treatment
by: Da Ran Kim, et al.
Published: (2024-09-01)

Risk factors for receiving both scleral buckle and glaucoma drainage device in children
by: Mariana Abi Karam, et al.
Published: (2024-10-01)

Influence of Environmental Factors with Clinical Signs and Symptoms in the Management of Dry Eye Disease
by: Muñoz-Villegas P, et al.
Published: (2024-08-01)

Efficacy and safety of the initial hypotensive treatment with an optimized latanoprost composition
by: S. Yu. Petrov, et al.
Published: (2023-12-01)

Dry Eye Epidemiology in Patients before Refractive Operations
by: S. N. Sakhnov, et al.
Published: (2018-03-01)

Diagnosis of Dry Eye Syndrome During the Preparing Patients for Cataracts Phacoemulsification. Literature Review
by: V. N. Trubilin, et al.
Published: (2024-06-01)

Varenicline Solution Nasal Spray 0.03 Mg for the Treatment of Dry Eye Disease Following Photorefractive Keratectomy
by: Ferguson TJ, et al.
Published: (2024-10-01)

Varenicline Solution Nasal Spray for the Treatment of Dry Eye Disease Following LASIK
by: Tanner J. Ferguson, et al.
Published: (2024-04-01)

Ocular surface condition in patients with pseudoexfoliative syndrome
by: V. V. Potemkin, et al.
Published: (2016-03-01)

The efficiency of monotherapy of patients with primary open-angle glaucoma with Bimatoprost 0.03 % (Bimoptic)
by: S. A. Korotkikh, et al.
Published: (2018-12-01)

Dry Eye Syndrome in the Practice of a Cataract Surgeon: A Clinical Case
by: N. V. Maychuk, et al.
Published: (2024-10-01)

Dry Eye Disease among Patients with Glaucoma under Topical Antiglaucoma Agents in a Tertiary Care Centre: A Descriptive Cross-sectional Study
by: Anjan Palikhey, et al.
Published: (2022-08-01)

Evaluation of Dry Eye Treatment with Sodium Hyaluronate- and Dexpanthenol-Containing Eye Drops on Ocular Surface Improvement after Cataract Surgery
by: Maximilian K. Köppe, et al.
Published: (2024-05-01)

Genome Wide Association Study of Neuropathic Ocular Pain
by: Jaxon J. Huang, BHSc, et al.
Published: (2024-03-01)

Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
by: T. I. Poltanova
Published: (2014-07-01)

Features of the complement system in primary open-angle glaucoma and dry eye syndrome in the elderly
by: N. M. Agarkov, et al.
Published: (2022-04-01)

Basics of Diagnosis and Treatment of Dry Eye Syndrome During Refractive Surgery
by: V. N. Trubilin, et al.
Published: (2024-06-01)